Compare Novo Nordisk A/S (NVO) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Energy Select Sector SPDR Fund — how do they compare? Novo Nordisk A/S trades at $45.08 (market cap $198.57B), while Energy Select Sector SPDR Fund trades at $65.69. The key difference: Novo Nordisk A/S pays a 4.03% dividend while Energy Select Sector SPDR Fund pays none, and Energy Select Sector SPDR Fund is trading nearer its 52-week high, Novo Nordisk A/S nearer its low. Which is the better fit depends on your goals.
| NVO | XLE | |
|---|---|---|
Market Cap | $198.57B | — |
Sector | Health | — |
52-Week High | $63.98 | $65.31 |
52-Week Low | $35.29 | $42.61 |
Enterprise Value | $213.37B | — |
Dividend Yield | 4.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novo Nordisk (NVO) trades at $45.16, down 3.09% on the day, with a bearish technical outlook. The stock shows strong fundamentals, including a P/E of 11.07, net income margin of 35.35%, and consistent earnings beats. Recent news highlights the launch of Wegovy pill in Germany and positive pediatric obesity trial results, though competition with Eli Lilly remains intense.
The outlook is mixed: strong profitability and analyst buy consensus (57.9%) support upside, but technical weakness and competitive pressures pose risks. Revenue growth is steady, with 2026 projections at $329.4B, but recent trial halts for cardiovascular drugs dim diversification prospects.
XLE, the Energy Select Sector SPDR ETF, trades at $64.78, up 1.12% amid bullish technical signals and strong sector momentum. The ETF benefits from rising oil prices, with Brent crude exceeding $100 per barrel due to Middle East tensions, as reported by Reuters on September 9, 2026. Technical indicators show a bullish moving average consensus, though the 6-day RSI at 78.15 suggests potential overbought conditions. Recent performance includes a 7.4% gain in August, leading sector ETFs, per ETF Trends on September 2, 2026.
Outlook remains positive driven by geopolitical supply risks and institutional optimism, with Goldman Sachs forecasting oil could reach $120 (Zacks, September 8, 2026). Key risks include oil price volatility and refining capacity constraints. The ETF's concentration in large caps like Exxon and Chevron offers stability, but investors face exposure to energy market cyclicality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
